NOVC Analysis

Novo Nordisk A/S
Stock Exchange: XETRA
Sector: pharmaceuticals
93.74
Last session price
93.74
Price now
Currency: EUR
Reporting currency: DKK
ISIN: DK0060534915
INN:
.

NOVC financial statements

* Numbers in millions
Capitalization * 215 331
EV * 213 569
Number of shares * 2 297
EPS 20,79
Revenue * 140 800
Net income * 47 757
Operating profit * 58 644
Total liabilities * 123 762
Net debt * 15 925
Total assets * 194 508
Equity * 70 746
Cash and investments * 17 485
.

NOVC valuation

P/E 4,51
P/B 3,04
P/S 1,53
E/P 22
P/FCF 4,52
.

NOVC profitability

ROE 68%
ROA% 32%
ROIC% 62%